Deadline for applications: 12 July 2024

TAG calls on Danaher to lower the price of GeneXpert tests for TB and other diseases to $5 each and to commit to public transparency of the cost audit of Xpert MTB/RIF Ultra.
SIGN the Time for $5 Campaign petition!

On 15 May 2024, Treatment Action Group (TAG) hosted a webinar on TB diagnostics pipeline: New tools & opportunities to improve access to testing.

The new 2024 update of An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP lays out what TB community advocates need to know about rifapentine-based TB preventive treatment.

On 15 May 2024, Treatment Action Group (TAG) will host a webinar on TB diagnostics pipeline: New tools & opportunities to improve access to testing.

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

Treatment Action Group (TAG) released an overview of TB research data reported at the 31st Conference on Retroviruses and Opportunistic Infections (CROI 2024) held on 3-6 March 2024 in Denver, Colorado, USA.

Treatment Action Group launches the 2023 Tuberculosis Treatment Pipeline Report.

Educational materials designed for community-based and civil society organizations to use to advocate for and teach people about TB preventive treatment.

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.